HUTCHMED (China) (HMDCF) Dividends Paid - Common (2021)
HUTCHMED (China)'s (HMDCF) quarterly Dividends Paid - Common came in at -$96.3 million in Q4 2021, down 199.34% quarter-over-quarter from $96.9 million in Q3 2021.
Powered by 
Analysis
HUTCHMED (China) (HMDCF) Dividends Paid - Common (2021) Analysis & Trends
HUTCHMED (China) (HMDCF) has reported Dividends Paid - Common for 1 consecutive years, with -$96.3 million the latest figure, recorded in Q4 2021.
- On a quarterly basis, Dividends Paid - Common changed N/A year-over-year to -$96.3 million in Q4 2021; TTM through Dec 2021 was $638000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $157.3 million, up 15627.4% from the prior year.
- Dividends Paid - Common was -$96.3 million for Q4 2021 at HUTCHMED (China), down from $96.9 million in the prior quarter.
- Over five years, Dividends Paid - Common peaked at $96.9 million in Q3 2021 and troughed at -$96.3 million in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.88 Bn | 197.89 Bn | 7.24 Bn | 1.36 Bn |
| 2 | Gilead Sciences | 181.55 Bn | 178.37 Bn | 6.22 Bn | 1.03 Bn |
| 3 | Vertex Pharmaceuticals | 132.31 Bn | 124.45 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.51 Bn | 74.52 Bn | 3.93 Bn | 96.80 Mn |
| 5 | Argenx Se | 61.54 Bn | 56.36 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.69 Bn | 49.55 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.07 Bn | 30.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.41 Bn | 30.12 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.10 Bn | 30.10 Bn | 1.16 Mn | - |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - | - |